XBiotech logo

XBiotech

XBIT | NASDAQ
Chart Builder DCF Calculator
$1.85
-$0.10 (-5.37%)
At close: Nov 16, 2026, 4:00 PM ET
$1.81
-$0.04 (-2.16%)
After-hours: Nov 16, 2026, 7:21 PM ET
-5.37%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
21.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #982/1021 (Top 96%)

Key Statistics

Market Data

Market Cap $56.4M
1D Range
1.81 1.97
52W Range
1.81 2.71

Valuation (TTM)

PE -1.29
PB 0.45
EV/EBITDA 1.21

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $0.00
Loading financial charts...

Profile

XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline...

Sector Healthcare
Industry Biotechnology
Employees 87
IPO Date Apr 15, 2015
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.